August 24th, 2016
An agent of demise
Harvard scientists identify spark plug that ignites nerve cell damage in Lou Gehrig’s disease
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Therapeutics
March 21st, 2016
Blavatnik Biomedical Accelerator at Harvard University announces license and collaboration agreement
Research alliance will advance small-molecule therapy for most common form of acute leukemia, targeting proteins involved in transcriptional regulation.
December 23rd, 2015
Targeting fat-tissue hormone may lead to type 2 diabetes treatment
UCB-funded Harvard study describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
September 28th, 2015
Attacking acute myeloid leukemia
A molecule isolated from sea sponges and synthesized at Harvard can halt the growth of cancerous cells.
April 1st, 2015
An alliance for better therapies
Through academic-industry partnership, a familiar toxin may become a lifesaver for patients with neuromuscular disorders
